Results 111 to 120 of about 19,810 (202)

Delayed Multisystem Deterioration Following Large-Volume Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Overdose. [PDF]

Cureus
Javed HM, Cuello S, Omer M, Buryk Y.
europepmc   +1 more source

Update in HIV therapy: Tenofovir alafenamide http://www.revmed.ch/contentrevmed/download/181028/1776439

, 2016
peer reviewedSince the first treatments against human immunodeficiency virus (HIV) have appeared in 1987, important progress has been accomplished. Twenty-four molecules are currently available but only some of them are in common use on account of their ...
Moutschen, Michel, DARCIS, Gilles, SAUVAGE, Anne-Sophie   +2 more
core  

Tenofovir Alafenamide Versus Entecavir as Switch Therapy After Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B. [PDF]

J Clin Med
Tsai HJ, Wu CH, Chen PY, Chen CC, Lin YC, Lee SW, Lin YS, Peng YC, Lee TY.   +8 more
europepmc   +1 more source

Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate. [PDF]

Clin Pharmacokinet
Waalewijn H, Bevers LAH, Lewis LL, Louey MD, Kawakatsu S, Zheng Y, Giaquinto C, Nardone A, Burger DM, Ter Heine R, Colbers A, Svensson EM.   +11 more
europepmc   +1 more source

Precision switching from entecavir to tenofovir alafenamide in chronic hepatitis B: matching the patient phenotype to efficacy, safety, and value: a narrative review. [PDF]

J Yeungnam Med Sci
Nam SW.
europepmc   +1 more source

Tenofovir alafenamide/tenofovir disoproxil fumarate

Reactions Weekly, 2021
openaire   +1 more source

Comments on "Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Lowering the Risk of Hepatocellular Carcinoma Development in Patients With Chronic Hepatitis B". [PDF]

J Gastroenterol Hepatol
Ullah W, Ashok K, Antar AS.
europepmc   +1 more source

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment. [PDF]

Open Forum Infect Dis
Ghosn J, Pulido F, Lopardo GD, Olczak A, Ripamonti D, Martin C, Paredes Ceballos O, Stocker H, Mendez Vazquez MJ, Gatanaga H, Metallidis S, Elbirt D, Whitlock G, Mateo González JI, Mohammed P, Wang K, Grove R, Wang R, Jewell A, Sutton K, Elliot E, Moodley R, Borsi R, Jones B, Kisare M, Budnik P, van Wyk J, VOGUE Study Group, VOGUE Study Group .   +28 more
europepmc   +1 more source

Assessing Renal Outcomes After Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People with HIV: Proteinuria Changes and Limits of Causal Attribution. [PDF]

Diseases
D'Anna T, Trizzino M, Belmonte B, Gioè C, Orlandi A, Zerbo S, Cicero A, Argo A, Cascio A.   +8 more
europepmc   +1 more source

Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study. [PDF]

Infect Dis Ther
Cossu MV, Moschese D, Matone M, Oreni L, Carrozzo G, Poloni A, Pozza G, Albini L, Forcina G, Gervasoni C, Riva A, Giacomelli A, Gori A.   +12 more
europepmc   +1 more source